Product Name CJC & Ipamorelin
Format 10mg Lyophilized Powder (5mg CJC-1295 / 5mg Ipamorelin)
Purity ≥99%
Molecular Formula Ipamorelin: C38H49N9O5, CJC-1295: C152H252N44O42
Molecular Weight Ipamorelin: 711.86 g/mol, CJC-1295: 3367.9 g/mol
Intended for research use only. Not for diagnostic or therapeutic purposes.
CJC-1295 and Ipamorelin are synthetic peptides commonly studied together for their complementary roles in growth hormone (GH) secretion research. CJC-1295 is a growth hormone–releasing hormone (GHRH) analog that promotes sustained GH pulse amplitude, while Ipamorelin is a selective growth hormone secretagogue that stimulates GH release via ghrelin receptor (GHS-R1a) activation without significantly impacting cortisol or prolactin levels.
In research settings, this peptide combination is frequently evaluated for its effects on growth hormone dynamics, metabolic regulation, tissue recovery models, and age-related changes in endogenous GH secretion. The combined formulation allows researchers to study synergistic GH signaling pathways in controlled laboratory environments.
Acknowledgment of Purchase
By placing an order with LumaPeptides, you affirm that the items are being obtained solely for legitimate research purposes.
Intended Use
LumaPeptides’ products are designed for use in laboratory research settings and should only be handled by trained professionals. These materials are not intended for medical, agricultural, pesticidal, food-related, or domestic use, and must not be represented or utilized as such. The information provided on this website is for educational reference only. Under no conditions should these products be introduced into humans or animals, as such action is against the law.
Important Notice
Peptides are not classified as dietary supplements. Research chemicals are intended strictly for scientific and medical research. They are not to be used in human or veterinary contexts. Labels on these products clearly state their intended use, thereby exempting them from certain federal regulations outlined in Title 21, Sections 100–740 of the Code of Federal Regulations (21 CFR).
Disclaimer
All products sold are strictly for research applications and are not suitable for human consumption.
FDA Statement
Products and information found on this site have not been reviewed by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health issue.
